SLU-PP-332 is a novel small-molecule compound that functions as an agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ), developed to regulate cellular energy metabolism and mitochondrial activity. By activating these nuclear receptors, it stimulates pathways involved in oxidative metabolism and energy expenditure, positioning it as a potential “exercise mimetic” in preclinical research.
Although not approved for medical use, SLU-PP-332 has gained attention in metabolic and performance research due to its ability to enhance mitochondrial function, increase endurance-related signaling, and promote fat utilization without direct stimulation of the central nervous system. Its unique mechanism allows it to mimic key aspects of aerobic exercise at the cellular level, making it of growing interest in studies focused on longevity, body recomposition, and metabolic optimization.
